New Ventures Portfolio Company, ADC Therapeutics, Completes $267 Million IPO

VIRGINIA BEACH, Va., June 30, 2020 /PRNewswire/ -- New Ventures Funds, a venture fund targeting investments in companies across healthcare and life sciences, is pleased to announce the IPO of its portfolio company, ADC Therapeutics (NYSE:ADCT)....
. .
Veröffentlicht von: - Nachrichten Ticker - Tuesday, 30 June

Share |